Close button
Enquiry IconContact Us
Logo
  • Choose License Type

Global Asthma Spacer Market, by Spacer Type (Volumatic, Aerochamber, InspirEase, Optichamber, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 1,637.5  Mn in 2021 and is expected to exhibit a CAGR of 6.4% during the forecast period (2021-2028), as highlighted in a new report published by Coherent Market Insights.

Rising adoption of asthma spacer or chamber for proper administration of medicine is anticipated to boost the global asthma spacer market growth over the forecast period. In the treatment of asthma, inhalation is the primary line of the treatment. Poor inhalation techniques, on the other hand, have resulted in poor disease control and higher health-care expenditures. The use of spacers/valve holding chambers reduces problems associated with the breathing method. It lowers oropharyngeal deposition while increasing lung deposition, which enhances the use of asthma spacers or chambers for appropriate asthma treatment.

Global Asthma Spacer Market– Impact of Coronavirus (COVID-19) Pandemic

The COVID-19 pandemic has affected the economy in three main ways including directly affecting the production and demand, creating disruptions in distribution channels, and through its financial impact on companies and financial markets. The pandemic has negatively impacted the development, production, and supply of medical devices, and affected the growth of the healthcare segment of various companies across the globe. This has led to closure of industrial establishments, except manufacturing of essential commodities and disruption in supply chain of products.

Supply chain and manufacturing activities in India, China, the U.S., and others have been disrupted due to lockdown. Whereas, the countries such as Thailand, Indonesia, Singapore, and others are facing problems with transportation of raw materials.

Browse 29 Market Data Tables and 33 Figures spread through 197 Pages and in-depth TOC on “Global Asthma Spacer Market”- Forecast to 2028, Global Asthma Spacer Market, by Spacer Type (Volumatic, Aerochamber, InspirEase, Optichamber, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in the Global Asthma Spacer Market, click the link below:

https://www.coherentmarketinsights.com/market-insight/asthma-spacers-market-3020

Increasing ozone exposure which is having negative impact on asthma patients is anticipated to boost the global asthma spacer market growth during the forecast period. For instance, in October 2018, according to U.S. Environmental Protection Agency, even at low levels and while the individuals were taking medicine to manage their asthma, an increase in ozone concentrations was related with a reduction in lung function. Ozone exposure was linked to a rise in the levels of fatty compounds in the blood. The study showed that ozone can have an impact on vulnerable groups even at low concentrations, and that the impact extends beyond respiratory consequences in asthma patients.

Key Takeaways of the Global Asthma Spacer Market:

  • Global asthma spacer market is expected to exhibit a CAGR of 6.4% during the forecast period owing increasing patient preference for metered dose inhaler (MDI) with spacer for management of asthma specifically in children. For instance, in December 2019, as per the JOJ Nursing & Health Care, inhaled short acting bronchodilators are the most commonly used first-line medications used to treat exacerbations of wheezing or asthma. The most often used methods for delivering these medicines are nebulizers and metered dose inhalers (MDIs) with spacers. Furthermore, MDIs with spacers are more efficient and easy method to deliver inhaled medicines to children.
  • Based on spacer type, others segment is estimated to account for largest market share in the global asthma spacer market in 2021. Quik spacer inhaler is one of the type of inhaler that included in others type segment, which is manufactured by Intas Pharmaceuticals Ltd. Spacers lengthen the time it takes for inhales to deliver medication, lowering the adverse effects such as oral thrush. As a result, an increasing number of patients are choosing for it which has positive impact on the segment growth.
  • In terms of distribution channel, hospital pharmacy segment is expected to constitute for a large market share in the global asthma spacer market in 2021. The hospitals can meet the immediate need for medications during operations and post-surgeries. Patients prefer to buy medicines from hospital pharmacies since consulting doctors are providing prescriptions from hospitals, which is expected to drive the segment growth.
  • Among regions, North America is expected to dominate the largest market share in the global asthma spacer market in 2021, due to increasing old age population. For instance, in the U.S., asthma affects between 4% and 13% of geriatric population. Asthma in older people of age 65 and above is shown to have a significant impact on quality of life.
  • Major players operating in the global asthma spacer market include Trudell Medical International, PARI Respiratory Equipment, Inc., Koninklijke Philips N.V, Lupin, GlaxoSmithKline Plc., Medical Developments International, Visiomed Group Ltd., Cipla Inc., Clement Clarke international Ltd., Rossmax International Ltd., Luckys Pharma, Mediacare Equipments (India) Pvt. Ltd., Asia Connection Co., Ltd., and Laboratoire Protecsom SAS.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner

Subscribe Newsletter

Kindly subscribe for our latest news & articles.